“I feel safe here”: Participants identify key components of syringe access programs

References

• Ajzen, I., & Fishbein, M. (1980). Understanding attitudes and predicting social behavior. Englewood Cliffs, NJ: Prentice-Hall.
   Google Scholar
• Ball, L., Venner, C., & Tirona, R. (2019). Heating injection drug preparation equipment used for opioid injection may reduce HIV transmission associated with sharing equipment. Journal of Acquired Immune Deficiency Syndromes, 81(4), 127–134.
   Web of Science ®Google Scholar
• Boucher, L. M., Marshall, Z., Martin, A., Larose-Hébert, K., Flynn, J. V., Lalonde, C., … Kendall, C. (2017). Expanding conceptualizations of harm reduction: Results from a qualitative community-based participatory research study with people who inject drugs. Harm Reduction Journal, 14(1), 18. doi:https://doi.org/10.1186/s12954-017-0145-2
   PubMed Web of Science ®Google Scholar
• Brooner, R., Kidorf, M., & King, V. (1998). Drug abuse treatment success among needle exchange participants. Public Health Reports, 113(S1), 129.
   PubMedGoogle Scholar
• Carlberg-Racich, S., & Roden, L. (2017). Barriers to patient-centered human immunodeficiency virus (HIV) care with African American patients who use drugs: Social construction of the typical and ideal care visit. Substance Abuse, 38(2), 205–212. doi:https://doi.org/10.1080/08897077.2017.1296527.
   Google Scholar
• Degenhardt, L., Peacock, A., Colledge, S., Leung, J., Grebely, J., Vickerman, P., … Larney, S. (2017). Global prevalence of injecting drug use and sociodemographic characteristics and prevalence of HIV, HBV, and HCV in people who inject drugs: A multistage systematic review. The Lancet. Global Health, 5(12), e1192–e1207. doi:https://doi.org/10.1016/S2214-109X(17)30375-3
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Arasteh, K., Hagan, H., McKnight, C., Perlman, D. C., & Friedman, S. R. (2009). Persistence and change in disparities in HIV infection among injection drug users in New York City after large-scale syringe exchange programs. American Journal of Public Health, 99(S2), S445–S451. doi:https://doi.org/10.2105/AJPH.2008.159327
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Arasteh, K., Torian, L. V., Hagan, H., Beatrice, S., … Friedman, S. R. (2005). Reductions in hepatitis C virus and HIV infections among injecting drug users in New York City, 1990–2001. AIDS, 19(3), S20–S25. doi:https://doi.org/10.1097/01.aids.0000192066.86410.8c
   PubMed Web of Science ®Google Scholar
• Des Jarlais, D. C., Perlis, T., Friedman, S. R., Deren, S., Chapman, T., Sotheran, J. L., … Marmor, M. (1998). Declining deroprevalence in a very large HIV epidemic; Injecting drug users in New York City, 1991 to 1996. American Journal of Public Health, 88(12), 1801–1806. doi:https://doi.org/10.2105/AJPH.88.12.1801
   PubMed Web of Science ®Google Scholar
• Doe-Simkins, M., Walley, A. Y., Epstein, A., & Moyer, P. (2009). Saved by the nose: Bystander-administered intranasal naloxone hydrochloride for opioid overdose. American Journal of Public health, 99(5), 788–791. doi:https://doi.org/10.2105/AJPH.2008.146647
   PubMed Web of Science ®Google Scholar
• Duvnjak, A., Morrison, E., Madden, A., & Olsen, A. (2015). No one likes using the dirties: A study into the re-use of injecting equipment in Australia. Canberra, Australia: Australian Injecting and Illicit Drug Users League (AVIL).
   Google Scholar
• Hagan, H., Des Jarlais, C., Friedman, S. R., Purchase, D., & Alter, M. J. (1995). Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. American Journal of public health, 85(11), 1531–1537. doi:https://doi.org/10.2105/AJPH.85.11.1531
   PubMed Web of Science ®Google Scholar
• Hagan, H., McGough, J. P., Thiede, H., Hopkins, S., Duchin, J., & Alexander, E.R. (2000). Reduced injection frequency and increased entry and retention in drug treatment associated with needle-exchange participation in Seattle drug injectors. Journal of Substance Abuse Treatment, 19(3), 247–252. doi:https://doi.org/10.1016/S0740-5472(00)00104-5
   PubMed Web of Science ®Google Scholar
• Heimer, R. (1998). Syringe exchange programs: Lowering the transmission of syringe-borne diseases and beyond. Public Health Reports, 113, 67.
   PubMedGoogle Scholar
• Heimer, R., Khoshood, K., Bigg, D., Guydish, J., & Junge, B. (1998). Syringe use and reuse: Effects of syringe exchange programs in four cities. Journal of Acquired Immune Deficiency Syndrome and Human Retrovirology, 18(1), S37–S44.
   PubMedGoogle Scholar
• Kerr, T., Small, W., Buchner, C., Zhang, R., Li, K., Montaner, J., & Wood, E. (2010). Syringe sharing and HIV incidence among injection drug users and increased access to sterile syringes. American Journal of Public Health, 100(8), 1449–1453. doi:https://doi.org/10.2105/AJPH.2009.178467
   PubMed Web of Science ®Google Scholar
• National Alliance of State and Territorial AIDS Directors. (2012). Syringe services program (SSP) development and implementation guidelines for state and local health departments. https://www.nastad.org/sites/default/files/resources/docs/055419_NASTAD-SSPGuidelines-August-2012.pdf
   Google Scholar
• Paquette, C. E., Syvertsen, J. L., & Pollini, R. A. (2018). Stigma at every turn: Health services experiences among people who inject drugs. The International Journal on drug policy, 57, 104–110. doi:https://doi.org/10.1016/j.drugpo.2018.04.004
   PubMed Web of Science ®Google Scholar
• Peters, P. J., Pontones, P., & Hoover, K. W. (2016). HIV infection linked to injection use of oxymorphone in Indiana. New England Journal of Medicine, 21(3), 2014–2015.
   Google Scholar
• Rushovich, T., Arwady, A., Salisbury-Afshar, E., Arunkumar, P., Kiely, M., Aks, S., & Prachand, N. (2018). Annual opioid surveillance report (Chicago, 2017). Chicago, IL: Chicago Department of Public Health.
   Google Scholar
• Shalala, D.E. (1998). Press release from Department of Health and Human Services. Retrieved from http://archive.hhs.gov/news/press/1998pres/980420a.html
   Google Scholar
• Sherman, S. G., Patel, S. A., Ramachandran, D. V., Galai, N., Chaulk, P., Serio-Chapman, C., & Gindi, R. M. (2015). Consequences of a restrictive syringe exchange policy on utilization patterns of a syringe exchange program in Baltimore, Maryland: Implications for HIV risk. Drug and Alcohol Review, 34(6), 637–644. doi:https://doi.org/10.1111/dar.12276
   PubMed Web of Science ®Google Scholar
• Treloar, C., Rance, J., & Backmund, M. (2013). Understanding barriers to hepatitis C virus care and stigmatization from a social perspective. Clinical Infectious Diseases, 57(2), S51–S55. doi:https://doi.org/10.1093/cid/cit263
   PubMed Web of Science ®Google Scholar
• United Nations Office on Drugs and Crime. (2015). World Drug Report 2015 (United Nations publication, Sales No. E.15.XI.6). Vienna: UNODC.
   Google Scholar
• United Nations Office on Drugs and Crime. (2019). World Drug Report 2019 (United Nations publication, Sales No. E.19.XI.8).
   Google Scholar
• Walley, A. Y., Xuan, Z., Hackman, H. H., Quinn, E., Doe-Simkins, M., Sorensen-Alawad, A., … Ozonoff, A. (2013). Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: Interrupted time series analysis. BMJ, 346, f174.
   PubMed Web of Science ®Google Scholar